PMA
P050047: JUVEDERM 24HV, JUVEDERM 30 AND JUVEDERM 30HV GEL IMPLANTS
FDA PMA · Implant, dermal, for aesthetic use · Allergan
Key facts
| PMA number | P050047 |
|---|---|
| Trade name | JUVEDERM 24HV, JUVEDERM 30 AND JUVEDERM 30HV GEL IMPLANTS |
| Generic name | Implant, dermal, for aesthetic use |
| Applicant | Allergan |
| Owner/operator | AbbVie, Inc. |
| Product code | LMH |
| Approval date | Jun 2, 2006 |
| Docket number | 06M-0235 |
| Notice date | Jun 29, 2006 |
| Establishment registration | 2011068 |
| FEI number | 2011068 |
At a glance
- 100–999 Supplements
- Aug 28, 2026 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- 10–99 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: